ru24.pro
News in English
Октябрь
2024

Новости за 31.10.2024

Thunder sign Malevy Leons, waive Alex Reese

InsideHoops.com 

The Oklahoma City Thunder has signed forward/center Malevy Leons, it was announced today by Executive Vice President and General Manager Sam Presti. And in a related move, the Thunder has waived forward/center Alex Reese. He was signed on Oct. 19 and appeared in one game. Leons (6-9, 205) appeared in four games (one start) for … Continue reading "Thunder sign Malevy Leons, waive Alex Reese"

Workers' warned Budget tax rises will hit their pay - BBC.com

Top Stories (uk) - Google News (ru) 

  1. Workers' warned Budget tax rises will hit their pay  BBC.com
  2. Budget 2024 summary: Key points from Rachel Reeves’s speech  BBC
  3. UK borrowing costs soar day after Labour government unveiled tax-raising budget  CNBC
  4. Britain is heading for oblivion, ruined by Labour’s greed, malice and stupidity  The Telegraph
  5. Starmer insists pro-growth policies on way after OBR’s budget warnings – UK politics live  The Guardian

How Trump Kept Biden's Gaffe From Getting Thrown Out

Real Clear Politics 

He wore an orange vest, walked to a white garbage truck, and climbed into the passenger's seat. "How do you like my garbage truck?" he asked reporters. "This truck is in honor of Kamala and Joe Biden."

Biden May Have Handed Trump a Big Assist

Real Clear Politics 

No one can say how this latest twist in a turbulent campaign will affect the final result. But in the vicious heat of the last week of the deadlocked presidential campaign, when even a few imprecise words can wreak significant political consequences, it may not matter what Biden really meant. Perception is everything.

Michelle Tarver faces challenges as new CDRH leader. But patient groups, industry are optimistic.

Center4research.org 

October 31, 2024: MedTech Dive news article quotes industry officials and NCHR and other patient and consumer advocates about new CDRH director Michelle Tarver and hopes for greater respect for patients, consumers, and researchers during user fee negotiations and FDA decision-making regarding the safety and effectiveness standards for medical devices.

Читать дальше...